v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (1,242,777) $ (1,124,743)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of securities (19,294) (2,176)
Loss on fair market value of equity investments 1,597
Gain on fair market value of derivatives (510,000) (1,284,000)
Share-based compensation:    
To directors – options 62,753
To key employees – options 12,229
To non-employees – options/RSUs 54,654 9,654
To non-employees – warrants 3,952  
Change in assets and liabilities:    
Deposits and other receivables 1,400 (2,482)
Prepaid expenses 59,974 (4,594)
Trade and other payables (1,083,318) (308,478)
License Fees Payable (551,154)
Net cash used by operating activities (3,286,563) (2,640,240)
Cash flows from investing activities:    
Purchases of marketable securities (144,977) (5,859,483)
Proceeds from sale of marketable securities 3,118,233 8,399,813
Net cash provided by/(used in) investing activities 2,973,256 2,540,330
Cash flows from financing activities    
Dividends on Preferred Stock (57,245)
Net proceeds from the exercise of warrants for common stock 511,175
Net cash provided by financing activities 453,930
Net increase/(decrease) in cash and cash equivalents 140,623 (99,910)
Cash and cash equivalents at beginning of period 986,996 173,154
Cash and cash equivalents at end of period 1,127,619 73,244
Cash paid for:    
Interest
Income Taxes
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Accrued dividends on Series G and Series H Convertible Preferred Stock 285,670
Fair value of Series G Convertible Preferred Stock issued in-lieu of dividends $ 656,000

Source

PDF HTML 10-Q Filing
ZIP HTML XBRL